Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|September 15, 2015
Treatment Options in Alzheimer´s Disease: The GABA StoryMaite Solas, Elena Puerta, Maria J Ramirez
Frontiers in Bioscience (Scholar Edition)|May 12, 2015
Object recognition test for studying cognitive impairments in animal models of Alzheimer's diseaseXabier Bengoetxea, Manuel Rodriguez-Perdigon, Maria J Ramirez
The American Journal of Clinical Nutrition|January 29, 2026
Associations between breastfeeding, childhood BMI and pubertal onset: Findings from a prospective cohort studyMaria J Ramirez-Luzuriaga, Madhumita Sinha, Robert L Hanson
Frontiers in Pharmacology|January 22, 2016
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's DiseaseRamon Yarza, Silvia Vela, Maite Solas, et al.
Neurobiology of Aging|July 6, 2012
CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patientsMaite Solas, Paul T Francis, Rafael Franco, et al.
CNS Drugs|December 4, 2016
Serotonin 5-HT<sub>6</sub> Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development StatusHilda Ferrero, Maite Solas, Paul T Francis, et al.
The International Journal of Neuropsychopharmacology|September 10, 2009
Signalling pathways associated with 5-HT6 receptors: relevance for cognitive effectsBeatriz Marcos, Maria Cabero, Maite Solas, et al.
Biochimica Et Biophysica Acta|March 12, 2013
Early cognitive stimulation compensates for memory and pathological changes in Tg2576 miceGorka Gerenu, Marta Dobarro, Maria J Ramirez, et al.
Journal of Alzheimer'S Disease : JAD|September 3, 2016
Purported Interactions of Amyloid-β and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's DiseaseXabier Bengoetxea, Adela López de Cerain, Amaya Azqueta, et al.
Drugs|May 8, 2014
Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current statusMaria J Ramirez, Mitchell K P Lai, Rosa M Tordera, et al.
Pageof 4